Bill Status of HB 5051   103rd General Assembly

Short Description:  PRIOR AUTH-PRESCRIPTION DRUGS

House Sponsors
Rep. Jenn Ladisch Douglass, Gregg Johnson, Kelly M. Cassidy, Margaret Croke, Mary Beth Canty and Lilian Jiménez

Last Action  View All Actions

DateChamber Action
  4/5/2024HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
215 ILCS 200/52 new

Synopsis As Introduced
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.

Actions 
DateChamber Action
  2/7/2024HouseFiled with the Clerk by Rep. Jenn Ladisch Douglass
  2/8/2024HouseFirst Reading
  2/8/2024HouseReferred to Rules Committee
  2/21/2024HouseAdded Co-Sponsor Rep. Gregg Johnson
  2/21/2024HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  2/26/2024HouseAdded Co-Sponsor Rep. Margaret Croke
  2/26/2024HouseAdded Co-Sponsor Rep. Mary Beth Canty
  3/5/2024HouseAssigned to Health Care Availability & Accessibility Committee
  3/20/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Jenn Ladisch Douglass
  3/20/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/21/2024HouseHouse Committee Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee
  4/5/2024HouseRule 19(a) / Re-referred to Rules Committee
  4/5/2024HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
  4/24/2024HouseAdded Co-Sponsor Rep. Lilian Jiménez

Back To Top